News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
204,405 Results
Type
Article (19695)
Company Profile (41)
Press Release (184669)
Section
Business (51177)
Career Advice (263)
Deals (7358)
Drug Delivery (31)
Drug Development (38874)
Employer Resources (21)
FDA (5957)
Job Trends (4901)
News (100481)
Policy (8077)
Tag
Academia (1477)
Alliances (14690)
Alzheimer's disease (1126)
Antibody-drug conjugate (ADC) (84)
Approvals (5966)
Artificial intelligence (82)
Best Places to Work (4637)
Breast cancer (184)
Cancer (1437)
Career advice (231)
CAR-T (77)
Cell therapy (217)
Clinical research (30597)
Collaboration (356)
Compensation (72)
COVID-19 (758)
C-suite (71)
Cystic fibrosis (51)
Data (991)
Diabetes (59)
Diagnostics (2071)
Earnings (17657)
Events (31842)
Executive appointments (223)
FDA (6448)
Funding (302)
Gene therapy (134)
GLP-1 (188)
Government (1206)
Healthcare (7612)
Infectious disease (796)
IPO (4052)
Job creations (493)
Job search strategy (198)
Layoffs (124)
Legal (954)
Lung cancer (227)
Lymphoma (85)
Manufacturing (66)
Medical device (3107)
Medtech (3109)
Mergers & acquisitions (3445)
Metabolic disorders (137)
Neurodegenerative disease (50)
Neuroscience (1393)
NextGen: Class of 2025 (1952)
Non-profit (3003)
Northern California (937)
Obesity (74)
Opinion (64)
Ovarian cancer (55)
Pancreatic cancer (52)
Parkinson's disease (85)
Patents (61)
People (16226)
Phase I (11284)
Phase II (13324)
Phase III (9578)
Pipeline (427)
Postmarket research (894)
Preclinical (4656)
Prostate cancer (55)
Radiopharmaceuticals (165)
Rare diseases (198)
Real estate (978)
Regulatory (6737)
Research institute (1368)
Series A (57)
Southern California (758)
Startups (1100)
United States (7592)
Vaccines (250)
Date
Today (29)
Last 7 days (337)
Last 30 days (1092)
Last 365 days (14303)
2025 (2172)
2024 (14502)
2023 (16676)
2022 (20467)
2021 (20799)
2020 (18130)
2019 (15527)
2018 (11559)
2017 (10681)
2016 (9930)
2015 (11170)
2014 (7552)
2013 (5799)
2012 (5779)
2011 (5805)
2010 (5057)
Location
Africa (161)
Asia (12946)
Australia (1908)
California (1974)
Canada (564)
China (213)
Colorado (96)
Connecticut (109)
Delaware (57)
Europe (26927)
Florida (253)
Georgia (54)
Illinois (186)
Indiana (95)
Japan (73)
Maryland (262)
Massachusetts (1622)
Minnesota (105)
New Jersey (593)
New York (658)
North Carolina (294)
Northern California (937)
Ohio (61)
Pennsylvania (422)
South America (210)
Southern California (758)
Texas (389)
Washington State (210)
204,405 Results for "pediatric brain tumor foundation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
The Pediatric Brain Tumor Foundation welcomes Day One Biopharmaceuticals’ renowned Dr. Samuel C. Blackman to its Board of Directors
January 31, 2025
·
4 min read
Business
Ursula Burns, former Xerox CEO, and Jordan Wertlieb, EVP and COO of Hearst, appointed to the Pediatric Brain Tumor Foundation’s Advisory Board as inaugural members
The Pediatric Brain Tumor Foundation announced the appointment of Ursula Burns and Jordan Wertlieb as inaugural members of the organization’s new Advisory Board.
June 25, 2024
·
5 min read
Press Releases
U.S. Food and Drug Administration Approves FoundationOne®CDx as a Companion Diagnostic for OJEMDA™ (tovorafenib) to Treat the Most Common Form of Childhood Brain Tumor in Pediatric Patients
January 17, 2025
·
5 min read
Press Releases
CBTN Partners with Day One to Drive New Therapies for Pediatric Brain Tumors
December 17, 2024
·
2 min read
Press Releases
Treovir and Matica Bio Forms Strategic Partnership to Advance Innovative Therapies for Pediatric Brain Tumors
December 4, 2024
·
3 min read
FDA
PNOC Foundation, a Leading Non-profit to Further Advancements in Pediatric Brain Cancer, Announces FDA Approval of Tovorafenib (Day101) in Partnership With PNOC Scientific Consortium and Day One Biopharmaceuticals
The Pediatric Neuro-Oncology Consortium Foundation, a platinum rated non-profit dedicated to supporting advancements in childhood brain cancer research and clinical trials, announces the FDA approval of Tovorafenib, a significant advancement in the fight against pediatric low-grade glioma brain tumors.
April 24, 2024
·
3 min read
Press Releases
BrainChild Bio, Inc. to Clinically Advance BCB-276, an Autologous B7-H3 Targeting CAR T-cell Therapy for Incurable Pediatric Brain Tumors
January 7, 2025
·
5 min read
Press Releases
TippingPoint Biosciences Closes New Funding to Support Drug for Rare Pediatric Brain Tumor
September 4, 2024
·
5 min read
FDA
Day One’s Ojemda Gets FDA Accelerated Approval for Pediatric Brain Tumor
The FDA on Tuesday approved Day One Biopharmaceuticals’ type II RAF inhibitor Ojemda, which is designed to penetrate the blood-brain barrier, for the treatment of relapsed or refractory pediatric low-grade glioma.
April 24, 2024
·
2 min read
·
Tristan Manalac
Brain cancer
Biopharma Takes on Deadly Brain Cancer After Decades of Failure
Emboldened by technological advances and a deeper knowledge of glioblastoma, Merck, Kazia Therapeutics, CorriXR Therapeutics and others are targeting the often-fatal brain tumor.
December 2, 2024
·
7 min read
·
Kate Goodwin
1 of 20,441
Next
